Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Gabriele Endler has worked on the following 1 EPO patent applications which have been published in the last five years:

EP15002128

ORAL FORMULATION COMPRISING BERBERINE AND MORUS ALBA EXTRACT

IPC classification:
A61K 31/045, A61K 31/445, A61K 31/4745, A61K 31/519, A61K 36/062, A61K 36/29, A61K 36/60, A61P 3/04, A61P 3/06
Agent:
F. R. Kelly & Co.
Agent:
Gabriele Endler, MEDA Pharma GmbH & Co. KG
Status:
APPLICATION PUBLISHED

Please Sign in to use this feature